Associate Professor Mark Danta
• Specialist Gastroenterologist and Hepatologist,
St Vincent's Hospital, Darlinghurst, Sydney.
• Associate Professor, Department of Medicine UNSW.
• Medical School postgraduate (Phd) co-ordinator.
• Bachelor of Medicine (University of Newcastle 1992)
• Diploma of Tropical Medicine and Hygiene (University of London 1996)
• Masters degree in Public Health (University of Sydney 2002)
• Doctorate in Medicine (University of London 2006)
• Fellow of the Royal Australasian College of Physicians (2002)
Areas of interest
A/Prof Danta's areas of interest include general gastroenterology, liver disease, management of viral hepatitis (hepatitis B & C) and HIV co-infection.
A/Prof Danta completed his undergraduate studies in medicine at the University of Newcastle NSW in 1992. He carried out his residency at St Vincent's Hospital, Sydney and completed his specialist training in Gastroenterology at the Royal North Shore Hospital, Sydney and the Royal Free Hospital, London.
Through medical work carried out in Asia, South and Central America, the Pacific Islands and central Australia, Mark developed his interest in liver disease and hepatitis. He completed a clinical fellowship in liver disease at the Royal Free and University College School of Medicine, London, UK between 2001-2003. Through this fellowship he developed a research interest in viral hepatitis completing his Doctorate on hepatits C and HIV co-infection through the University College London, University of London between 2004-2006.
In 2007 Mark returned to St Vincent's as a Staff Specialist and a Senior Lecturer in Medicine with UNSW.
His individual and collaborative research has led to a number of significant peer reviewed publications (also see research). His main research interests include: viral hepatitis, clinical hepatology and gastrointestinal mucosal immunology. He has been funded through a number of peer reviewed grants from NH&MRC, Cancer Institute NSW, University of NSW and St Vincent’s Clinic Foundation among others. He continues his research into viral hepatitis.
Mark also has an active role in collaboration with the Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, trialing new therapies for viral hepatitis.
He lives in central Sydney with his family.